Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Metadata
Title
False-Positive Plasma (1↙3)-β-D-Glucan Test following Immunoglobulin Product Replacement in an Adult Bone Marrow Recipient
Authors
Masahiro Ogawa
Hiroki Hori
Shigeko Niiguchi
Eiichi Azuma
Yoshihiro Komada
Publication date
01-07-2004
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 1/2004
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.04030

Other articles of this Issue 1/2004

International Journal of Hematology 1/2004 Go to the issue

OriginalPaper

Clinical Relevance of Survivin as a Biomarker in Neoplasms, Especially in Adult T-Cell Leukemias and Acute Leukemias

Case Report

Sustained Cytogenetic Remission Induced by Imatinib Mesylate in a Chronic Myeloid Leukemia Patient Who Had a Relapse into Lymphoid Crisis after Allogeneic Hematopoietic Stem Cell Transplantation

OriginalPaper

Unmanipulated HLA-Haploidentical Bone Marrow Transplantation for the Treatment of Fatal, Nonmalignant Diseases in Children and Adolescents

Case Report

t(11;18)-Bearing Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Responding to Cladribine

OriginalPaper

Glanzmann Thrombasthenia Associated with a 21-Amino Acid Deletion (Leu817-Gln837) in Glycoprotein IIb due to Abnormal Splicing in Exon 25

OriginalPaper

Vascular Endothelial Growth Factor and Other Signaling Pathways in Developmental and Pathologic Angiogenesis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits